Invitrogen IVGN Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Invitrogen IVGN

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: tuck who wrote (11)	12/4/2005 4:40:51 AM
From: mopgcw	Read Replies (1) of 73

17-Nov-05 6:11 PM Hoffmeister David F Chief Financial Officer 1,530 Market Purchase 16-Nov-05 $65.02 $99,483.82 5% view interesting indeed. I have been poking around it for a bit now, but not pulled the trigger. i started to really get interested in the low 60's but the 3rd quarter gave me a little pause. best i can tell, growth has only been through acquisitions with little growth in original business and costs wnet up a lot. i dont mind r&d increases, but sales costs and amortization costs went up as well. bioreliance is still having problems. I do like the free cashflow, and they have been quite successful in the past, so I am still trying to figure out the right entry price.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next